TGFB1 and systemic sclerosis: Recent studies suggest that antiangiogenic factors such as VEGF165b, together with proinflammatory (CD40L) and profibrotic (TGF-β) factors secreted by platelets, can contribute to the progression of peripheral microvascular damage and defective vascular repair in SSc (161).